For: | Yang CJ, Chiu CT, Yeh YC, Chao A. Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report. World J Clin Cases 2022; 10(2): 625-630 [PMID: 35097088 DOI: 10.12998/wjcc.v10.i2.625] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i2/625.htm |
Number | Citing Articles |
1 |
Keisuke Maeda, Toshihisa Ichiba, Kenichiro Kashiwa, Yuji Okazaki. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal. Cureus 2023; doi: 10.7759/cureus.47088
|
2 |
|
3 |
Jing Zhao, Wei-Bo Wang, Hui Ding, Hua-Jun Fu, Yan-An Jiang, Zhiqian Zhang. Prevention of Dexmedetomidine on Postoperative Delirium and Early Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Thoracoscopic Lobectomy. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5263021
|
4 |
Ken Shimada, Yutaro Kase, Makoto Nakatsuru, Hideki Tanzawa. Neuroleptic malignant syndrome in fields other than psychiatry. Oral Science International 2023; 20(3): 165 doi: 10.1002/osi2.1171
|